Task order 2 under RFP-12-100-SOL-00016

Ended Awarded Last action

Contract number
HHSO10033002T
Awardee
Awarding agency
Obligated
$13,943,972

Award facts

Opportunity
  • 12100SOL00016 Solicitation number
Contract value 100% obligated
$13,943,972.12 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Bridgewater, NJ 08807, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00003 · Close the contract in line with far 4.804 $0
Other Administrative Action 2 · Acquisition of a colony stimulating factor (g- or GM-CSF) as a medical countermeasure for neutropeni -$48,978
Other Administrative Action 1 · The purpose of this modification is to finalize the novation agreement. Via this novation modification the united states government recognizes that all… $0
Original award $13,992,950

About this award

This contract award to Partner Therapeutics, Inc. is for a Task Order under the HHS Colony Stimulating Factor 2013-2018 Indefinite Delivery/Indefinite Quantity (ID/IQ) contract. The task order, valued at $13,943,972.12, is for the acquisition of a Colony Stimulating Factor (G- or GM-CSF) as a medical countermeasure for neutropenia. The contract is a Firm Fixed Price Delivery Order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the Department of Health and Human Services (HHS). This award does not have a set-aside designation. Partner Therapeutics, a biopharmaceutical company based in Massachusetts, has been awarded numerous prime contracts and ID/IQ vehicles by HHS and the Department of Defense (DoD) to provide drugs, pharmaceuticals, and research services to support medical countermeasures and preparedness efforts.

Quick answers

Who was awarded contract HHSO10033002T?

HHSO10033002T was awarded to Partner Therapeutics, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 30, 2013.

How much is contract HHSO10033002T worth?

The government has obligated $13,943,972 on HHSO10033002T.

Is contract HHSO10033002T an order under another contract?

Yes. HHSO10033002T is a delivery order under HHSO100201300005I, an indefinite delivery contract, on HHS Colony Stimulating Factor 2013-2018.

Was contract HHSO10033002T competed?

The extent of competition for HHSO10033002T was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award